On November 18, 2026 Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class cancer therapies, reported that members of the company’s management team will present at the following investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
9th Annual Evercore Healthcare Conference
Presentation Date/Time: December 1, 2026, at 9:10 a.m. ET
Piper Sandler 38th Annual Healthcare Conference
Presentation Date/Time: December 2, 2026, at 10:30 a.m. ET
Interested parties can access live audio webcasts of these presentations via the Investor Relations section of the company’s website at www.immunome.com. Replay webcasts will be available for approximately 30 days following the live presentations.
(Press release, Immunome, NOV 18, 2026, View Source [SID1234674934])